The pharmaceutically active compound theophylline (T) was cocrystallised with the amides formamide (1), acetamide (2), N-methylformamide (3) , N,N-dimethylformamide (4), benzamide (5) and pyrazinamide (6) , with systems T:1, T:5 and T:6 displaying polymorphic behaviour. The cocrystals with formamide (T:1), acetamide (T:2) and benzamide (T:5), and one polymorph of the cocrystal with pyrazinamide (T:6-I), contain an R 2 (9) hydrogen bonding motif between the amide cocrystal formers and the HN-C-C=O moiety of the theophylline molecule (an amide-pseudo amide synthon). This motif was, however, absent from the other polymorph of the pyrazinamide cocrystal (T:6-II), and also from the N-methylformamide cocrystal (T:3) (and is not possible in the N,N-dimethylformamide cocrystal (T:4)). These observations are rationalised using hydrogen bond propensity calculations, although limitations of using such calculations for predicting cocrystallisation are noted. The amide-pseudo amide synthon is favoured when theophylline cocrystallises with both primary amides and with secondary amides which are locked in a cis configuration. On heating, all cocrystals were found to dissociate before melting due to loss of the amide, making stability to dissociation a more meaningful measure of cocrystal stability than melting point for these systems. On dissociation of the cocrystals, theophylline typically crystallises as the commonly observed polymorph Form II. In the case of the acetamide cocrystal (T:2), however, the rarely observed metastable polymorph, Form V, crystallises concomitantly with Form II suggesting that cocrystal dissociation on heating could be a strategy for generating novel polymorphic forms of compounds.
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Introduction
In recent years, cocrystallisation has emerged as a strategy for improving the solid state properties of compounds, [1] [2] [3] and has received increasing interest in many sectors of chemistry including the pharmaceutical industry. 4, 5 Cocrystals are crystal forms where two or more neutral molecules are present in the unit cell, 6, 7 and can be prepared by a variety of approaches including solution crystallisation, solid state grinding, thermal methods, freeze-drying and slurrying. [8] [9] [10] [11] [12] [13] An important consideration with cocrystallisation is that not every pair of molecules has the propensity to form a cocrystal. In fact, identifying species (coformers) which will cocrystallise with a given compound can sometimes be an arduous process. 14 When screening for cocrystals, a typical first step is to consider the functional groups that are present in the compound of interest and to select coformers that have complementary groups which might be expected to form strong hydrogen bonding interactions. 15 Such a synthon based approach can be aided by using the Cambridge Structural Database (CSD)
to identify interactions which form robustly in known crystal structures, and systematic surveys of these interactions, also referred to as supramolecular synthons, 16 have been conducted. 17, 18 This has been taken further through the development of a hydrogen bond propensity tool which calculates, on the basis of previously reported crystal structures, the likelihood of each of interactions between the hydrogen bond donor and acceptor groups in a given molecule (or in multiple molecules), and can be used to predict whether two molecules will cocrystallise. 19, 20 Cocrystallisation has also been predicted on the basis of parameters such as the sizes and shapes of coformers. 21 While there has been much focus on understanding which compounds will form cocrystals, and optimum methods for preparing cocrystals, less attention has been paid to the equally important areas of cocrystal polymorphism and cocrystal stability. [22] [23] [24] [25] During early studies into the cocrystallisation of pharmaceutical compounds, it was speculated that cocrystals may show less of a propensity for polymorphic behaviour as they would be expected to have fewer unsatisfied hydrogen bonding groups. 22, 26 In fact, the number of reports of cocrystal polymorphism is similar to that for single component phases, 27, 28 and any historical differences are more likely to be due to difficulties associated with screening for different polymorphic forms of cocrystals than to an inherent tendency for cocrystals to be monomorphic. 13, 29 Cocrystal stability is not yet well understood, but studies have shown that cocrystals can dissociate spontaneously on heating or through partial dissolution of one of the coformers.
2, 24, 25, [30] [31] [32] Theophylline is a pharmaceutically active compound used as a treatment for asthma and COPD for which seven polymorphic forms have been reported. [33] [34] [35] [36] [37] [38] Over 40 cocrystals of theophylline are present in the Cambridge Structural Database (version 5.36, see Supporting Information Table S1 ), three of which comprise coformers having an amide functionality (a 1:1 cocrystal of theophylline and saccharin, a 1:1 cocrystal of theophylline and urea, and a 2:1 cocrystal monohydrate of theophylline and 5-fluorouracil). [39] [40] [41] In each case, there is an R 2 (9) hydrogen bonding motif between the HN-C-C=O moiety of the theophylline molecule and the amide group of the coformer ( Figure 1 ). This interaction, which will be referred to here as an amide-pseudo amide motif, has not previously been considered as a synthon in supramolecular chemistry. (e) A schematic of the amide-pseudo amide motif (graph set notation R 2 (9)) which is present in the structures shown in (a-c).
In this study, the robustness of the amide-pseudo amide interaction is investigated by cocrystallising theophylline with a series of amides: formamide, acetamide, 
Experimental
All chemicals were purchased from Sigma-Aldrich and used as received. Powder X-ray diffraction analysis was performed on a Philips X'Pert Diffractometer equipped with an X'celerator RTMS detector using CuKα radiation at a wavelength of 1.5406 Å. Data were collected between 3 and 50° 2θ at ambient temperature using a collection time of 5 minutes. Powders were pressed gently on a glass slide to give a level surface. PXRD overlays are plotted with an arbitrary intensity scale and were generated using X'Pert Highscore software. Measurements at non-ambient temperature were made using an Anton Paar TK450 heating stage (see Supporting Information).
Single crystal X-ray data were collected at 180 K (unless stated) on a Nonius Kappa CCD diffractometer equipped with an Oxford Cryosystems cooling device using MoKα radiation. The theophylline:acetamide cocrystal crystal structure was collected and solved by the EPSRC UK National Crystallographic Service at the University of Southampton 44 on a Bruker Nonius Instrument with KappaCCD area detector (φ scans and ω scans to fill asymmetric unit sphere).
The crystal structure of theophylline:pyrazinamide cocrystal Form II was determined from powder X-ray data. The powder pattern was indexed using the program DICVOL06. 45 The crystal structure was solved by a Simulated Annealing algorithm implemented in the program EXPO 2014. 46 Rietveld refinement 47 was performed using the program TOPAS Academic 4.1. 48 The background was modelled by a Chebyshev polynomial and the peak shape was modelled by a pseudo-Voigt function. Correction of preferred orientation by the March-Dollase 49 method was applied to the (111) crystallographic plane. Throughout the refinement, molecules were treated as rigid bodies, with the exception of a flexible parameter defined to permit rotation of the amide group of pyrazinamide molecule. The refined crystal structure was geometry-optimised using the plane-wave DFT code CASTEP 8.0. 50 The calculation was performed using the PBE 51 functional with G06 52 dispersion correction and norm-conserving pseudopotentials. 53 The plane wave cutoff and k-point spacing were set to 700 eV and 0.03 Å -1 ,
respectively. The unit cell parameters were fixed during the optimisation. Molecular geometries extracted from the optimised structure were used in the final Rietveld refinement. The covalent bonds to hydrogen atoms were shortened by 0.15 Å to account for the displacement of electron density towards the heavy atoms.
Hydrogen bond propensity calculations were performed using the Solid Form module Differential scanning calorimetry (DSC) thermograms were recorded in a nitrogen atmosphere using a Mettler Toledo STARe DSC822e/700 calorimeter using a heating rate of 10 °C.min -1 . Endotherms are plotted as downward peaks. Samples were prepared in 40 µl aluminum pans which were sealed using a cold weld.
Results
Cocrystallisation between theophylline and formamide (T and 1), and between theophylline and acetamide (T and 2), was attempted experimentally by grinding (ethanol was added to the latter to facilitate conversion), yielding a new crystal form in each case.
Single crystals of these new phases suitable for X-ray structure determination were obtained from solution crystallisations and they were each determined to be of 1 It is noted that the existence of a theophylline:acetamide cocrystal has previously been postulated by Abourahma et al on the basis of powder X-ray diffraction data. 54 The full crystal structure of the 1:1 theophylline acetamide cocrystal reported here confirms this earlier observation.
The fact that theophylline cocrystallises with formamide and acetamide indicates that theophylline-amide interactions are favoured over amide-amide and theophyllinetheophylline interactions for these pairs of molecules. In order to further probe this potential competition between homo and hetero interactions, cocrystallisation was attempted between theophylline and the bulkier amides benzamide (5) and pyrazinamide (6) , and also with the amides N-methylformamide (3) and DMF (4), for which fewer theophylline-amide interactions are possible. Furthermore, pyrazinamide possesses two aromatic nitrogen atoms which could potentially act as hydrogen bond acceptors.
Cocrystallisation occurred with theophylline and each of the four amides, and the crystal structures were determined demonstrating a 1:1 theophylline to amide ratio in each case.
The hydrogen bonding arrangements are shown in Figure 4 . Figure S10 ). Form II is the most commonly observed theophylline polymorph, whereas Form V is a seldom observed crystal form that has been previously isolated during supercritical antisolvent crystallisations of theophylline, 35 and in trace amounts during crystallisations from methanol. 36 Here, thermal dissociation of the acetamide cocrystal has provided an alternative route to observing this unusual crystal form of theophylline, albeit as a minor phase in a mixture with Form II.
Cocrystal Polymorphism
Although no extensive crystal form screening was performed during this study, second Crystallographic data for the reported theophylline:amide cocrystal structures are given in Table 1 . 
0126 -* This structure was solved using powder X-ray diffraction data.
Discussion
The Amide-Pseudo Amide Interaction
The R 2 (9) amide-pseudo amide motif is present in the formamide (both polymorphs), acetamide and benzamide cocrystals of theophylline, and in one of the polymorphs of the pyrazinamide cocrystal, but is absent from the N-methylformamide and DMF cocrystals (though it should be noted that there is no possibility of forming this interaction with DMF as this molecule has no hydrogen bond donor). From these observations it can be concluded that the amide-pseudo amide motif is a highly favourable interaction. On considering a wider set of theophylline:amide cocrystals, including both those reported here and the theophylline:amide cocrystals published in the CSD, it is evident that the amide-pseudo amide motif is seen with all of the primary amides (formamide, acetamide, benzamide, pyrazinamide and urea) and with secondary amides which are locked in a cis conformation, i.e. due to being part of a ring (saccharin and 5-fluorouracil). For other secondary amide coformers (N-methylformamide, paracetamol and sulfacetamide), where cocrystals with theophylline do not contain the amidepseudo amide motif, it appears that adopting a trans geometry gives a greater energetic stabilisation than forming this interaction. The exception to this trend is the 2:1 theophylline:phenobarbital cocrystal, where, despite the cis arrangement of the amide moieties of 2 the conformer, the amide-pseudo amide interaction does not occur, probably because this would lead to the formation of discrete trimers of molecules rather than the observed extended hydrogen bonded chains.
Hydrogen bond propensities
In order to place the above observations into the wider context of known crystal structures hydrogen bond propensity calculations were performed for each of the pairs of molecules (theophylline + amide) which were found to cocrystallise in this study. These calculations take into account which functional groups are involved in hydrogen bonding interactions in the crystal structures of similar molecules present in the CSD, and were generated using the Solid Form module in the Mercury v3.3 software package. For example, the hydrogen bond donor and acceptor groups of theophylline (T) and the amides acetamide (2), DMF (4) and N-methylformamide (3) are labelled in Figure 7 , and the resulting propensity values for the pairs of molecules theophylline/formamide and theophylline/acetamide are listed in Table 2 . Table 2 . Table 2 . Table showing 
For the pair of molecules theophylline and acetamide, the hydrogen bond calculated to have the highest likelihood of formation is that between the NH 2 and C=O moieties of acetamide (groups labelled d2 and a4 in Figure 7 ). Taken in isolation, this result would suggest that acetamide molecules are more likely to interact with each other, rather than with theophylline molecules, making cocrystallisation between theophylline and acetamide unlikely. When hydrogen bonding propensities relating to the NH donor group of theophylline (d1) are taken into consideration, however, it is evident that there is a much greater likelihood of this group interacting with the amide oxygen of acetamide (a4) than with an acceptor group from another theophylline molecule. In fact, the interactions that comprise an amide-pseudo amide interaction between theophylline and acetamide molecules (between groups d1 + a4 and d2 + a1) are significantly more likely to occur than any of the possible theophylline-theophylline interactions.
This indicates there that there is competition as to whether it is the hydrogen bond donor group of acetamide (d2) or of theophylline (d1) that will interact with its preferred acceptor. The fact that theophylline and acetamide undergo cocrystallisation in practice suggests that overall theophylline-acetamide interactions are more favourable than the average of acetamideacetamide and theophylline-theophylline interactions, but it would have been difficult to predict with confidence 'a priori' whether cocrystallisation between theophylline and acetamide will occur without further calculations (such as determination of the relative lattice energies of coformers and the cocrystal through crystal structure prediction).
Propensity calculations for theophylline with formamide, benzamide and pyrazinamide are broadly similar to those for theophylline and acetamide (see Supporting Information Table S2 ), which is unsurprising given the identical hydrogen bonding motifs seen in the four corresponding cocrystal structures.
As the molecule DMF does not possess a hydrogen bond donor group, the only donor for the theophylline/DMF system is the imidazole NH group of theophylline (d1). In the crystal structure, this group forms the interaction that has the highest calculated propensity, that to the amide oxygen of DMF (a5).
With N-methylformamide, the theophylline NH hydrogen bond donor group (d1) interacts with its most likely acceptor, the amide carbonyl oxygen (a6). The amide NH hydrogen bond donor group (d3) does not, however, interact with the theophylline carbonyl group (a1) to give an amide-pseudo amide motif, instead forming a hydrogen bond to the imidazole nitrogen of theophylline (a3). The amide NH group has a similar likelihood of interacting with the carbonyl group and the imidazole nitrogen (0.63 and 0.53 respectively), and the fact that an interaction with a1 requires a higher energy cis conformation of the amide (given that the d1 -a6 interaction is also present) explains why the interaction with a3 is seen experimentally.
Importantly, because formamide and N-methylformamide are liquids at room temperature, the most likely interaction, that between the NH and C=O groups of the amide (groups d2/d3 and a4/a6), is less relevant to a consideration of crystal forms. As theophylline-amide interactions are significantly more likely than theophylline-theophylline interactions, it would have been possible to predict in advance that cocrystallisation would occur, as observed experimentally.
Interestingly, when cocrystallisation between theophylline and N-methylbenzamide, an N-methyl substituted amide which is solid at room temperature, was attempted by liquid assisted grinding, no cocrystal formation occurred. Clearly, in this system there is competition between amideamide and theophylline-amide interactions, and it appears that the amide-amide interactions are dominant.
Form II of the theophylline:pyrazinamide cocrystal is the only theophylline:amide cocrystal structure identified in this study where amide-amide hydrogen bonds, which have the highest calculated propensity, are actually observed. Moreover, this crystal form highlights a limitation of using hydrogen bond propensities to predict the likelihood that two compounds will cocrystallise. Even in a situation where the coformers form homosynthons, rather than heterosynthons, giving dimers or chains of the same molecule, there is still a possibility that cocrystallisation will occur if these units interact through secondary hydrogen bonds (as in the case of T:6-II), or favourable dispersive interactions. For this reason, other predictive tools (such as crystal structure prediction) will generally prove to be more robust for determining whether a pair of molecules will cocrystallise.
Conclusions
The robustness of the amide-pseudo amide interaction was probed by preparing a set of theophylline:amide cocrystals. This motif was noted to form reliably, both with primary amides and secondary amides locked in a cis geometry, indicating that should be treated as a plausible synthon for the purposes of crystal engineering. Hydrogen bond propensity calculations were useful for rationalising interactions in the theophylline:amide cocrystal structures, but would not have given 'a priori' a clear indication of whether cocrystallisation would or would not occur in these systems. Furthermore, cocrystallisation was observed to occur in a system in which the two coformers did not interact through a strong hydrogen bond (theophylline:pyrazinamide, T:6-II),
and it is noted that such a situation is not taken into account when using hydrogen bond propensities to predict cocrystal formation. In addition, there is an indication that it may be important to make a distinction between whether coformers are solid or liquid at room temperature when predicting the likelihood of cocrystal formation as less hydrogen bond competition would be expected for liquid coformers.
On heating in an open system, each of the theophylline:amide cocrystals isolated in this study dissociated through loss of the amide coformer prior to melting. Dissociation temperature is a more important measure of thermal stability for these cocrystals than melting point, and it is likely that such a situation will be common for cocrystals in general (where one or both of the coformers become volatile at a temperature below the melting point of the cocrystal).
Dissociation of the theophylline:acetamide cocrystal on heating yielded the rarely observed Form V of theophylline, demonstrating that cocrystallisation/thermal dissociation cycles could be a route to preparing novel or unusual metastable polymorphic forms of compounds. The desolvation of solvates is a widely used method of exploring polymorphism of compounds, [61] [62] [63] but to the knowledge of the authors this is the first example to demonstrate that cocrystal formation/thermal dissociation may provide a method of exploring polymorphism of a compound by giving access to alternate crystallisation conditions. 
